「すべてのCookieを受け入れる」をクリックすると、サイトのナビゲーション向上、サイト利用状況の分析、 およびマーケティング活動の支援のために、お使いのデバイスにCookieを保存することに同意したものとみなされます。
プライバシーポリシー
??????????????????2024??141?9000??????????2025???2034????????????CAGR?7.3??????2034?????287?1000???????????????
| ???? | ?? |
| 2025?????? | 152?3000???? |
| 2034??????? | 287?1,000???? |
| 2025???2034??????CAGR | 7.3% |
| ??????? | ???????????? |
| ???? | ??????AG; ?????; ???????AG; LFB; ??????SA; CSL; ??????????; ?????; BDI???????? |
?????????????????????????????????????????????????????????????????????????????IVIG????????????????????????????????????????IVIG?????????????????????????????? ??????????????1,000????????????????????????G?IgG????????????????????????????????????????????????????????????????????????????????
???????????IVIG??T???B????????????????????????????????????????????????????????????????????????????????? ????????????????????????????????????????????PAD???????????????????????SLE??????????????????????????????????????????? IVIG????????????????????????IVIG????????60%??80%?????????
?????????????R&D????????????????????????????????R&D???????????????????????????????????????????????????????R&D??????????????????????????????????????????????????????? R&D?????????????????????????????????????????????????????????????????????????????????????R&D???????????????????????R&D???????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????G????????1????????????????????????????????????????????????????????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????pH????????????? ???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
Volza????????????????2022?12???2023?11??????????23??????????????????????????10???????11??????????????????????-23%?????????
発行元 Deepa Pandey
| サブセグメント | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunodeficiency diseases | - | - | - | - | - | - | - | - | - | - | - |
| CIDP | - | - | - | - | - | - | - | - | - | - | - |
| Hypogammaglobulinemia | - | - | - | - | - | - | - | - | - | - | - |
| Congenital AIDS | - | - | - | - | - | - | - | - | - | - | - |
| Chronic Lymphocytic Leukemia | - | - | - | - | - | - | - | - | - | - | - |
| Myasthenia Gravis | - | - | - | - | - | - | - | - | - | - | - |
| Multifocal motor neuropathy | - | - | - | - | - | - | - | - | - | - | - |
| ITP | - | - | - | - | - | - | - | - | - | - | - |
| Kawasaki disease | - | - | - | - | - | - | - | - | - | - | - |
| Guillain-Barre syndrome | - | - | - | - | - | - | - | - | - | - | - |
| Others | - | - | - | - | - | - | - | - | - | - | - |
| サブセグメント | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | - | - | - | - | - | - | - | - | - | - | - |
| Specialty Pharmacies | - | - | - | - | - | - | - | - | - | - | - |
| Other | - | - | - | - | - | - | - | - | - | - | - |
To get full access to our Market Insights, you need a Professional Account or a Business Suite.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.